Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Medical Records, Problem-Oriented | 1 | 2020 | 15 | 0.89 | Why? |
| Cardiac Pacing, Artificial | 2 | 2020 | 160 | 0.85 | Why? |
| Pacemaker, Artificial | 2 | 2020 | 431 | 0.68 | Why? |
| 3-Iodobenzylguanidine | 1 | 2016 | 25 | 0.68 | Why? |
| Ion Channels | 1 | 2018 | 167 | 0.63 | Why? |
| Myocardial Ischemia | 2 | 2020 | 781 | 0.56 | Why? |
| Takotsubo Cardiomyopathy | 2 | 2020 | 453 | 0.54 | Why? |
| Ventricular Outflow Obstruction | 1 | 2010 | 23 | 0.44 | Why? |
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2006 | 11 | 0.33 | Why? |
| Atherectomy, Coronary | 1 | 2006 | 35 | 0.31 | Why? |
| Fluid Therapy | 1 | 2010 | 628 | 0.30 | Why? |
| Hypertension, Pulmonary | 4 | 2018 | 970 | 0.29 | Why? |
| Arrhythmias, Cardiac | 1 | 2019 | 2510 | 0.28 | Why? |
| Ventricular Remodeling | 2 | 2019 | 349 | 0.28 | Why? |
| Coronary Stenosis | 1 | 2006 | 273 | 0.24 | Why? |
| Echocardiography, Three-Dimensional | 2 | 2019 | 135 | 0.21 | Why? |
| Ventricular Dysfunction, Right | 2 | 2017 | 639 | 0.20 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.19 | Why? |
| Ventricular Function, Right | 3 | 2018 | 388 | 0.19 | Why? |
| Echocardiography | 5 | 2019 | 3661 | 0.18 | Why? |
| Electric Countershock | 1 | 2020 | 284 | 0.17 | Why? |
| Cardiotonic Agents | 2 | 2018 | 418 | 0.17 | Why? |
| Consensus Development Conferences as Topic | 1 | 2017 | 93 | 0.17 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2017 | 68 | 0.16 | Why? |
| Pyridazines | 1 | 2017 | 86 | 0.16 | Why? |
| Cardiac Resynchronization Therapy | 1 | 2019 | 191 | 0.16 | Why? |
| Acute Coronary Syndrome | 2 | 2020 | 2107 | 0.16 | Why? |
| Remote Sensing Technology | 1 | 2020 | 351 | 0.16 | Why? |
| Prosthesis Implantation | 1 | 2019 | 261 | 0.16 | Why? |
| Coronary Circulation | 1 | 2018 | 188 | 0.16 | Why? |
| Hydrazones | 1 | 2017 | 216 | 0.15 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.15 | Why? |
| Smoking Prevention | 1 | 2017 | 116 | 0.15 | Why? |
| Radionuclide Imaging | 1 | 2016 | 184 | 0.15 | Why? |
| Cardiologists | 1 | 2020 | 366 | 0.15 | Why? |
| Mitral Valve Insufficiency | 1 | 2019 | 302 | 0.14 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 520 | 0.14 | Why? |
| Heart Ventricles | 3 | 2017 | 1139 | 0.14 | Why? |
| Angiotensin Receptor Antagonists | 2 | 2020 | 3892 | 0.13 | Why? |
| Factor Xa Inhibitors | 1 | 2019 | 490 | 0.13 | Why? |
| Magnetic Resonance Imaging | 5 | 2021 | 6551 | 0.13 | Why? |
| Heart Failure | 3 | 2020 | 6638 | 0.13 | Why? |
| Heart Valve Prosthesis | 1 | 2019 | 533 | 0.13 | Why? |
| Myocardial Infarction | 2 | 2021 | 3361 | 0.13 | Why? |
| Pyridones | 1 | 2019 | 738 | 0.12 | Why? |
| Heart Valve Prosthesis Implantation | 1 | 2019 | 552 | 0.12 | Why? |
| Healthy Lifestyle | 1 | 2017 | 447 | 0.12 | Why? |
| Probiotics | 1 | 2020 | 694 | 0.12 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 5277 | 0.12 | Why? |
| Exercise Tolerance | 1 | 2017 | 634 | 0.11 | Why? |
| Cardiomyopathies | 1 | 2021 | 997 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Italy | 7 | 2021 | 38444 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Pyrazoles | 1 | 2019 | 1791 | 0.09 | Why? |
| Dietary Supplements | 1 | 2020 | 2251 | 0.09 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.09 | Why? |
| ST Elevation Myocardial Infarction | 2 | 2021 | 3051 | 0.09 | Why? |
| Diet | 1 | 2020 | 2052 | 0.09 | Why? |
| Hypertension | 2 | 2020 | 8895 | 0.08 | Why? |
| Drug Administration Schedule | 3 | 2019 | 2324 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Administration, Oral | 3 | 2019 | 2340 | 0.08 | Why? |
| Humans | 32 | 2021 | 930598 | 0.08 | Why? |
| Stroke | 2 | 2020 | 8839 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.07 | Why? |
| Heart | 2 | 2021 | 1791 | 0.07 | Why? |
| beta-Thalassemia | 1 | 2008 | 200 | 0.07 | Why? |
| Breast Diseases | 1 | 2005 | 75 | 0.07 | Why? |
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2004 | 56 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2019 | 2320 | 0.07 | Why? |
| Coronary Angiography | 2 | 2020 | 2275 | 0.06 | Why? |
| Infusions, Intravenous | 2 | 2018 | 1224 | 0.06 | Why? |
| Reoperation | 1 | 2006 | 544 | 0.06 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.06 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 226 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2019 | 10649 | 0.06 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.06 | Why? |
| Pulmonary Artery | 2 | 2021 | 803 | 0.06 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2006 | 365 | 0.06 | Why? |
| Exercise Test | 2 | 2018 | 911 | 0.05 | Why? |
| Cardiac Catheterization | 2 | 2018 | 882 | 0.05 | Why? |
| Male | 16 | 2021 | 367725 | 0.05 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.05 | Why? |
| Prosthesis Failure | 1 | 2020 | 195 | 0.05 | Why? |
| Stents | 1 | 2006 | 916 | 0.05 | Why? |
| Aged, 80 and over | 8 | 2020 | 88759 | 0.05 | Why? |
| Aged | 11 | 2020 | 215776 | 0.05 | Why? |
| Vasculitis | 1 | 2005 | 691 | 0.05 | Why? |
| Prosthesis Design | 1 | 2020 | 594 | 0.04 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Time Factors | 4 | 2020 | 31397 | 0.04 | Why? |
| Rome | 1 | 2017 | 497 | 0.04 | Why? |
| Drug Substitution | 1 | 2019 | 385 | 0.04 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.03 | Why? |
| Ultrasonography | 1 | 2010 | 4409 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2020 | 676 | 0.03 | Why? |
| Body Mass Index | 2 | 2017 | 4306 | 0.03 | Why? |
| Defibrillators, Implantable | 1 | 2020 | 624 | 0.03 | Why? |
| Risk Factors | 5 | 2021 | 71621 | 0.03 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.03 | Why? |
| European Union | 1 | 2017 | 565 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Animals | 2 | 2020 | 78931 | 0.03 | Why? |
| Biopsy | 1 | 2020 | 2811 | 0.03 | Why? |
| Patient Acceptance of Health Care | 2 | 2020 | 5002 | 0.03 | Why? |
| Female | 11 | 2020 | 380317 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Registries | 2 | 2020 | 12327 | 0.03 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.02 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.02 | Why? |
| Diagnosis, Differential | 2 | 2017 | 7220 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2020 | 1962 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2020 | 2517 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Critical Illness | 1 | 2010 | 17281 | 0.02 | Why? |
| Hemorrhage | 1 | 2019 | 3013 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Vitamin D | 1 | 2020 | 2904 | 0.02 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Mammography | 1 | 2005 | 410 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.01 | Why? |
| Diagnostic Imaging | 1 | 2004 | 1044 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Breast Neoplasms | 1 | 2005 | 3633 | 0.01 | Why? |
Fedele's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(197)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_